- Home
- KRO vs OPK Comparison
KRO vs OPK Comparison
Compare KRO & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRO
- OPK
- Stock Information
- Founded
- KRO 1916
- OPK 2007
- Country
- KRO United States
- OPK United States
- Employees
- KRO N/A
- OPK N/A
- Industry
- KRO Major Chemicals
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- KRO Industrials
- OPK Health Care
- Exchange
- KRO Nasdaq
- OPK Nasdaq
- Market Cap
- KRO 598.2M
- OPK 1.0B
- IPO Year
- KRO N/A
- OPK 1995
- Fundamental
- Price
- KRO $6.14
- OPK $1.38
- Analyst Decision
- KRO Strong Sell
- OPK Buy
- Analyst Count
- KRO 2
- OPK 4
- Target Price
- KRO $7.75
- OPK $2.75
- AVG Volume (30 Days)
- KRO 350.9K
- OPK 1.9M
- Earning Date
- KRO 11-05-2025
- OPK 11-06-2025
- Dividend Yield
- KRO 3.32%
- OPK N/A
- EPS Growth
- KRO 3452.79
- OPK N/A
- EPS
- KRO 0.59
- OPK N/A
- Revenue
- KRO $1,892,000,000.00
- OPK $664,029,000.00
- Revenue This Year
- KRO $5.77
- OPK N/A
- Revenue Next Year
- KRO $11.07
- OPK $0.84
- P/E Ratio
- KRO $10.27
- OPK N/A
- Revenue Growth
- KRO 6.51
- OPK N/A
- 52 Week Low
- KRO $4.70
- OPK $1.11
- 52 Week High
- KRO $12.98
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- KRO 50.24
- OPK 50.29
- Support Level
- KRO $6.07
- OPK $1.34
- Resistance Level
- KRO $6.39
- OPK $1.44
- Average True Range (ATR)
- KRO 0.24
- OPK 0.04
- MACD
- KRO -0.02
- OPK -0.00
- Stochastic Oscillator
- KRO 38.60
- OPK 40.00
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.